Evidence map›Paper›PMID 32668794›Full record

ArticleInternational journal of molecular sciences2020

From Inflammation to Cutaneous Repair: Topical Application of Lupeol Improves Skin Wound Healing in Rats by Modulating the Cytokine Levels, NF-κB, Ki-67, Growth Factor Expression, and Distribution of Collagen Fibers.

Fernando Pereira Beserra, Lucas Fernando Sérgio Gushiken, Ana Júlia Vieira, Danilo Augusto Bérgamo, Patrícia Luísa Bérgamo, Mariana Oliveira de Souza, Carlos Alberto Hussni, Regina Kiomi Takahira, Rafael Henrique Nóbrega, Emanuel Ricardo Monteiro Martinez and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Bioactivity-Guided Isolation of Stigmasterol fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Wound-Healing Efficacy ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Wound-Healing Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Mechanism of the effect ofOpen veterinary journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Fernando Pereira BeserraDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Lucas Fernando Sérgio GushikenDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Ana Júlia VieiraDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Danilo Augusto BérgamoDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Patrícia Luísa BérgamoDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Mariana Oliveira de SouzaDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Carlos Alberto HussniDepartment of Surgery and Veterinary Anesthesiology, School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Regina Kiomi TakahiraDepartment of Clinics Veterinary, School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Botucatu 18618-681, São Paulo, Brazil.ORCID 0000-0003-3323-4199
Rafael Henrique NóbregaDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.ORCID 0000-0001-9796-5076
Emanuel Ricardo Monteiro MartinezDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Christopher John JacksonKolling Institute of Medical Research, The University of Sydney at Royal North Shore Hospital, St. Leonard, NSW2065 Sydney, Australia.
Gabriela Lemos de Azevedo MaiaDepartment of Pharmacy, Federal University of São Francisco Valley (UNIVASF), Petrolina 56304-205, Pernambuco, Brazil.
Ariane Leite RozzaDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Cláudia Helena PellizzonDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.
Universidade Estadual Paulista (Unesp) · BRThe University of Sydney · AUUniversidade Federal do Vale do São Francisco · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/23340-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/23247-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/17600-1
6 · The paper itself

Abstract

Skin wound healing is a highly complex event that involves different mediators at the cellular and molecular level. Lupeol has been reported to possess different biological activities, such as anti-inflammatory, antioxidant, antidiabetic, and in vitro wound healing properties, which motivated us to proceed with in vivo studies. We aimed to investigate the wound healing effect of lupeol-based cream for 3, 7, and 14 days. Wound excisions were induced on the thoraco-lumbar region of rats and topically treated immediately after injury induction. Macroscopic, histopathological, and immunohistochemical analyses were performed. Cytokine levels were measured by ELISA and gene expression was evaluated by real-time RT-qPCR. Our results showed a strong wound-healing effect of lupeol-based cream after 7 and 14 days. Lupeol treatment caused a reduction in proinflammatory cytokines (TNF-a, IL-1β, and IL-6) and gene and protein NF-κB expression, and positively altered IL-10 levels, showing anti-inflammatory effects in the three treatment periods. Lupeol treatment showed involvement in the proliferative phase by stimulating the formation of new blood vessels, increasing the immunostaining of Ki-67 and gene expression, and immunolabeling of vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF), and increasing gene expression of transforming growth factor beta-1 (TGF-β1) after seven days of treatment. Lupeol was also involved in the tissue regeneration phase by increasing the synthesis of collagen fibers noted in the three treatment periods analyzed. Our findings suggest that lupeol may serve as a novel therapeutic option to treat cutaneous wounds by regulating mechanisms involved in the inflammatory, proliferative, and tissue-remodeling phases.

Indexed as

PhytotherapyAdministration, CutaneousAnimalsAnti-Inflammatory AgentsCollagenCytokinesDermatologic AgentsGene Expression RegulationInflammationIntercellular Signaling Peptides and ProteinsKi-67 AntigenLupanesMaleNeovascularization, PhysiologicNF-kappa BPentacyclic TriterpenesAnti-Inflammatory AgentsCollagenCytokinesDermatologic AgentsIntercellular Signaling Peptides and ProteinsKi-67 AntigenLupaneslupeolNF-kappa BPentacyclic TriterpenesRNA, Messengercutaneous wound healinglupeolnatural productskin regenerationtriterpene

Identifiers

PMID32668794
PMCPMC7404060
OpenAlexW3041940810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.